MCID: EXT010
MIFTS: 48

Extramedullary Plasmacytoma

Categories: Cancer diseases, Immune diseases, Blood diseases

Aliases & Classifications for Extramedullary Plasmacytoma

MalaCards integrated aliases for Extramedullary Plasmacytoma:

Name: Extramedullary Plasmacytoma 12 14 69
Plasmacytoma, Extramedullary 12
Extraosseous Plasmacytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3720
ICD10 33 C90.2 C90.20
NCIt 47 C4002
UMLS 69 C0278619

Summaries for Extramedullary Plasmacytoma

MalaCards based summary : Extramedullary Plasmacytoma, also known as plasmacytoma, extramedullary, is related to plasmacytoma and anaplastic plasmacytoma. An important gene associated with Extramedullary Plasmacytoma is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Innate Immune System and Akt Signaling. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and colon, and related phenotypes are cardiovascular system and cellular

Related Diseases for Extramedullary Plasmacytoma

Diseases related to Extramedullary Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 131)
id Related Disease Score Top Affiliating Genes
1 plasmacytoma 11.4
2 anaplastic plasmacytoma 11.1
3 multiple myeloma 10.4
4 hypogonadotropism 10.3 B2M IL6
5 primary biliary cirrhosis 10.3 B2M IL6
6 hepadnavirus infection 10.3 B2M IL6
7 angiomatous meningioma 10.3 B2M IL6
8 thyroiditis 10.3
9 myotubular myopathy, x-linked 10.3 CCND1 CDKN1A
10 plummer's disease 10.3 B2M IL6
11 late yaws 10.3 B2M IL6
12 spirillary rat-bite fever 10.3 IL2 IL6
13 x-linked dominant intellectual disability-epilepsy syndrome 10.3 IL2 IL6
14 immunodeficiency 11a 10.2 B2M IL2
15 labyrinthine bilateral reactive loss 10.2 IL2 IL6
16 lymphocytic colitis 10.2 IL2 IL6
17 tinea favosa 10.2 IL2 IL6
18 orthostatic proteinuria 10.2 IL2 IL6
19 cyclosporiasis 10.2 IL2 IL6
20 central nervous system origin vertigo 10.2 B2M IL2
21 hemophagocytic lymphohistiocytosis 10.2 IL2 IL6
22 foodborne botulism 10.2 IL2 IL6
23 early congenital syphilis 10.2 IL2 IL6
24 endocervical adenocarcinoma 10.2 CDKN1A IL2
25 unilateral retinoblastoma 10.1 CCND1 CDKN1A
26 orbital osteomyelitis 10.1 IL2 IL6
27 pharynx cancer 10.1 CCND1 CDKN1A
28 lysosomal storage disease 10.1 BCL2 CCND1
29 extramedullary soft tissue plasmacytoma 10.1
30 abnormal retinal correspondence 10.1 IL2 IL6
31 tonsillitis 10.1
32 blake pouch cyst 10.1 B2M BCL2
33 lymphoma 10.1
34 esophagus melanoma 10.1 IL2 IL6
35 hip subluxation 10.0 BCL2 CCND1
36 oral antidiabetic drugs toxicity or dose selection 10.0 BCL2 CCND1
37 legionellosis 10.0 IL2 IL6
38 mediastinitis 10.0
39 melanoma metastasis 10.0 BCL2 CCND1
40 myelitis 10.0 IL2 IL6
41 hodgkin's lymphoma, mixed cellularity 10.0 CCND1 CDKN1A
42 sinusitis 10.0
43 nasopharyngitis 10.0
44 cervicitis 10.0
45 pancreatitis 10.0
46 amyloidosis 10.0
47 laryngeal adenoid cystic carcinoma 10.0 BCL2 CCND1
48 cpt deficiency, hepatic, type ia 10.0 B2M CCND1 IL6
49 heterotaxy, visceral, 4, autosomal 9.9 BCL2 IL6
50 adenocarcinoma 9.9

Graphical network of the top 20 diseases related to Extramedullary Plasmacytoma:



Diseases related to Extramedullary Plasmacytoma

Symptoms & Phenotypes for Extramedullary Plasmacytoma

MGI Mouse Phenotypes related to Extramedullary Plasmacytoma:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.97 B2M BCL2 CCND1 CDKN1A IL2 IL6
2 cellular MP:0005384 9.95 IL2 IL6 B2M BCL2 CCND1 CDKN1A
3 digestive/alimentary MP:0005381 9.93 B2M BCL2 CCND1 CDKN1A IL2 IL6
4 endocrine/exocrine gland MP:0005379 9.91 BCL2 CCND1 CDKN1A IL2 IL6 B2M
5 hematopoietic system MP:0005397 9.88 B2M BCL2 CCND1 CDKN1A IL2 IL6
6 immune system MP:0005387 9.85 B2M BCL2 CCND1 CDKN1A IL2 IL6
7 neoplasm MP:0002006 9.73 B2M BCL2 CCND1 CDKN1A IL2 IL6
8 integument MP:0010771 9.72 BCL2 CCND1 CDKN1A IL6 B2M
9 reproductive system MP:0005389 9.63 B2M BCL2 CCND1 CDKN1A IL2 IL6
10 respiratory system MP:0005388 9.35 BCL2 CCND1 CDKN1A IL2 IL6
11 vision/eye MP:0005391 9.02 BCL2 CCND1 CDKN1A IL2 IL6

Drugs & Therapeutics for Extramedullary Plasmacytoma

Drugs for Extramedullary Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 219)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
3
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
4
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
5
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
6
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
7
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
8
Ondansetron Approved Phase 3 99614-02-5 4595
9
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
10
Guaifenesin Approved, Vet_approved Phase 3 93-14-1 3516
11
Morphine Approved, Investigational Phase 3 57-27-2 5288826
12
Dalteparin Approved Phase 3 9005-49-6
13
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
14
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
15
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
16
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
17
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
18
Ginseng Approved, Nutraceutical Phase 3 50647-08-0
19
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
20 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
21 Alkylating Agents Phase 3,Phase 2,Phase 1
22 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
23 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
24 Antiemetics Phase 3,Phase 2,Phase 1
25 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
26 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
27 Antirheumatic Agents Phase 3,Phase 2,Phase 1
28 Autonomic Agents Phase 3,Phase 2,Phase 1
29 BB 1101 Phase 3,Phase 2
30 Dexamethasone acetate Phase 3,Phase 2 1177-87-3
31 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
32 glucocorticoids Phase 3,Phase 2,Phase 1
33 HIV Protease Inhibitors Phase 3,Phase 2,Phase 1
34 Hormone Antagonists Phase 3,Phase 2,Phase 1
35 Hormones Phase 3,Phase 2,Phase 1
36 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
37 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
38 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
39
protease inhibitors Phase 3,Phase 2,Phase 1
40 Proteasome Inhibitors Phase 3,Phase 1
41 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
42 Analgesics Phase 3
43 Anesthetics Phase 3
44 Anesthetics, Dissociative Phase 3
45 Anesthetics, General Phase 3
46 Anesthetics, Intravenous Phase 3
47 Central Nervous System Depressants Phase 3,Phase 1,Phase 2
48 Excitatory Amino Acid Antagonists Phase 3
49 Excitatory Amino Acids Phase 3
50 Neurotransmitter Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 68)

id Name Status NCT ID Phase Drugs
1 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
4 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
5 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
6 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
7 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
8 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
9 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
10 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
11 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
12 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
13 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
14 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
15 Beta Alethine in Treating Patients With Myeloma Unknown status NCT00006466 Phase 1, Phase 2 beta alethine
16 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
17 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Completed NCT00002657 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisone;vincristine sulfate
18 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
19 Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation Completed NCT00005606 Phase 2
20 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Completed NCT00002504 Phase 2
21 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
22 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
23 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
24 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
25 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2 cyclophosphamide
26 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate
27 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
28 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
29 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
30 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Recruiting NCT02547662 Phase 2 Dexamethasone;Ixazomib Citrate;Pomalidomide
31 Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow Recruiting NCT00003838 Phase 2
32 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Active, not recruiting NCT01849783 Phase 2 dexamethasone;cisplatin;doxorubicin;cyclophosphamide;etoposide;bortezomib;thalidomide;melphalan
33 S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Terminated NCT00109889 Phase 2
34 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Terminated NCT00337506 Phase 2 Dexamethasone;velcade
35 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn NCT01101412 Phase 1, Phase 2 Edetate Calcium Disodium;Ethanol;Trimethoprim-sulfamethoxazole
36 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Unknown status NCT00004036 Phase 1 amifostine trihydrate;carboplatin;cyclophosphamide
37 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
38 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction Completed NCT00025415 Phase 1 imatinib mesylate
39 PS-341 in Treating Patients With Advanced Cancer Completed NCT00006362 Phase 1 bortezomib
40 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Completed NCT00005634 Phase 1 vorinostat
41 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Completed NCT00002980 Phase 1 decitabine
42 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer Completed NCT00003451 Phase 1
43 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00003331 Phase 1 fluorouracil;leucovorin calcium;topotecan hydrochloride
44 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer Completed NCT00003082 Phase 1
45 Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed NCT00004904 Phase 1 cladribine;cyclophosphamide;etoposide;methylprednisolone;tacrolimus
46 Pyroxamide in Treating Patients With Advanced Cancer Completed NCT00042900 Phase 1 pyroxamide
47 EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer Completed NCT00004258 Phase 1 cilengitide
48 Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed NCT00004232 Phase 1 cyclosporine;methylprednisolone;prednisone
49 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer Completed NCT00036790 Phase 1 doxorubicin hydrochloride;motexafin gadolinium
50 Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Active, not recruiting NCT01588015 Phase 1

Search NIH Clinical Center for Extramedullary Plasmacytoma

Genetic Tests for Extramedullary Plasmacytoma

Anatomical Context for Extramedullary Plasmacytoma

MalaCards organs/tissues related to Extramedullary Plasmacytoma:

39
Bone, Bone Marrow, Colon, Breast, Thyroid, Liver, Pancreas

Publications for Extramedullary Plasmacytoma

Articles related to Extramedullary Plasmacytoma:

(show top 50) (show all 523)
id Title Authors Year
1
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
2
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
3
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
4
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
5
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
6
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
7
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
8
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
9
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
10
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
11
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
12
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
13
Extramedullary Plasmacytoma Presenting With Acute Airway Compromise, Treated With Emergent Rigid Bronchoscopic Resection. ( 27058726 )
2016
14
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. ( 27847663 )
2016
15
Endoscopic ultrasound-fine needle aspiration: A novel way to diagnose a solitary extramedullary plasmacytoma of the liver. ( 27080614 )
2016
16
Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy. ( 27066407 )
2016
17
Primary Extramedullary Plasmacytoma in the Gastroduodenal Canal Associated With Epstein-Barr Virus-Associated Adenocarcinoma of the Stomach: A Case Report. ( 27466321 )
2016
18
Retroperitoneal laparoscopic management of a solitary extramedullary plasmacytoma associated with human immunodeficiency virus infection: A case report. ( 26870281 )
2016
19
Extramedullary Plasmacytoma of the Gallbladder Detected on Fluorine 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. ( 27761300 )
2016
20
Establishment of an innovative staging system for extramedullary plasmacytoma. ( 27717354 )
2016
21
Primary Plurifocal Extramedullary Plasmacytoma of Breast. ( 27059937 )
2016
22
Double Extramedullary Plasmacytoma of the Stomach with a Long-term Endoscopic Follow-up. ( 27980257 )
2016
23
Atrophoderma of Pasini and Pierini associated with extramedullary plasmacytoma. ( 27443586 )
2016
24
Solitary extramedullary plasmacytoma of the colon, rectum and anus. ( 28240504 )
2016
25
Extramedullary plasmacytoma of the gingiva. ( 26887880 )
2016
26
Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series. ( 28050154 )
2016
27
Extramedullary Plasmacytoma Diagnosed in an HIV-Positive Patient by an Unusual Clinical Presentation. ( 27980867 )
2016
28
Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management. ( 27054435 )
2016
29
Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone. ( 27408443 )
2016
30
Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. ( 27200157 )
2016
31
Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report. ( 27284562 )
2016
32
Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid. ( 28017340 )
2016
33
Unusual Cause of Sphenoidal Sinus Mass: Extramedullary Plasmacytoma. ( 27779089 )
2016
34
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case. ( 27980740 )
2016
35
Extramedullary plasmacytoma of the cricoid cartilage progressing to multiple myeloma: A case report. ( 25789038 )
2015
36
Extramedullary plasmacytoma mimicking colon carcinoma: an unusual presentation and review of the literature. ( 26498668 )
2015
37
A 65-year old female with synchronous HIV and Extramedullary Plasmacytoma of Maxillary sinus. ( 26499825 )
2015
38
Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma. ( 26450521 )
2015
39
Extramedullary plasmacytoma of the small intestine. ( 25760181 )
2015
40
Pulmonary plasmacytoma with endobronchial extension: A rare presentation of solitary extramedullary plasmacytoma: A case report and brief review of literature. ( 26881595 )
2015
41
Extramedullary Plasmacytoma of the Larynx Treated by a Surgical Endoscopic Approach and Radiotherapy. ( 26137339 )
2015
42
Solitary Extramedullary Plasmacytoma of the Orbital Apex and Dura Masquerading as Idiopathic Inflammation. ( 26226234 )
2015
43
Irradiation combined with surgery for function preservation in the treatment of extramedullary plasmacytoma of the left labia majora during pregnancy: A case report. ( 26722319 )
2015
44
Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma. ( 26528383 )
2015
45
An extramedullary plasmacytoma in the testicle: A case report and review of the literature. ( 26085896 )
2015
46
Solitary extramedullary plasmacytoma of thoracic epidural space presenting with dorsal compressive myelopathy: A case report and review of literature. ( 26167030 )
2015
47
Primary extramedullary plasmacytoma of ovary: Report of a rare neoplasm. ( 26881544 )
2015
48
Unusual coexistence of extramedullary plasmacytoma and nasopharyngeal carcinoma in nasopharynx. ( 26376733 )
2015
49
The t(11;14)(q13;q32) Translocation as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma. ( 25812994 )
2015
50
Unusual Extramedullary Plasmacytoma: A Rare but Possible Cause of Lymphadenopathy in Chronic Lymphocytic Leukemia. ( 26236345 )
2015

Variations for Extramedullary Plasmacytoma

Expression for Extramedullary Plasmacytoma

Search GEO for disease gene expression data for Extramedullary Plasmacytoma.

Pathways for Extramedullary Plasmacytoma

Pathways related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 47)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.77 B2M BCL2 CCND1 CDKN1A IL2 IL6
2
Show member pathways
13.18 BCL2 CCND1 CDKN1A IL2 IL6
3
Show member pathways
12.84 B2M BCL2 CCND1 CDKN1A IL2 IL6
4
Show member pathways
12.66 B2M CCND1 IL2 IL6
5
Show member pathways
12.59 CCND1 CDKN1A IL2 IL6
6 12.46 BCL2 CCND1 CDKN1A IL6
7
Show member pathways
12.41 BCL2 CCND1 CDKN1A
8
Show member pathways
12.41 BCL2 IL2 IL6
9
Show member pathways
12.36 BCL2 CDKN1A IL2 IL6
10
Show member pathways
12.34 BCL2 CCND1 CDKN1A IL6
11 12.33 BCL2 CCND1 CDKN1A
12 12.25 BCL2 CCND1 CDKN1A IL2 IL6
13
Show member pathways
12.22 CCND1 CDKN1A IGKC
14 12.14 CCND1 CDKN1A IL2 IL6
15
Show member pathways
12.1 BCL2 CCND1 CDKN1A
16
Show member pathways
12.07 BCL2 CCND1 CDKN1A
17 12.02 CCND1 CDKN1A IL6
18
Show member pathways
11.96 CCND1 CDKN1A IL6
19
Show member pathways
11.93 CCND1 CDKN1A IL6
20 11.91 BCL2 CCND1 CDKN1A
21 11.85 CCND1 IL2 IL6
22 11.82 BCL2 CCND1 CDKN1A
23 11.78 BCL2 CDKN1A IL6
24 11.73 BCL2 CCND1 IL6
25 11.72 BCL2 CDKN1A IL6
26 11.64 BCL2 CCND1 CDKN1A
27 11.6 CDKN1A IL2 IL6
28
Show member pathways
11.59 BCL2 CCND1 CDKN1A IL2 IL6
29 11.56 BCL2 CCND1 CDKN1A
30 11.51 BCL2 CCND1 CDKN1A IL6
31
Show member pathways
11.45 CCND1 IL2 IL6
32 11.42 BCL2 CCND1 CDKN1A
33 11.39 CCND1 CDKN1A
34 11.35 BCL2 CDKN1A
35 11.33 CCND1 CDKN1A
36 11.32 BCL2 CCND1 IL6
37
Show member pathways
11.28 BCL2 IL2
38 11.25 CCND1 CDKN1A IL6
39 11.22 CCND1 IL6
40 11.2 CCND1 IL6
41 11.17 CCND1 CDKN1A
42 11.14 IL2 IL6
43 11.07 BCL2 IL2
44 11.05 BCL2 IL2 IL6
45
Show member pathways
10.99 BCL2 CDKN1A
46 10.91 BCL2 IL6
47 10.73 BCL2 CCND1 CDKN1A IL2 IL6

GO Terms for Extramedullary Plasmacytoma

Cellular components related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.13 B2M IGKC IL6
2 cyclin-dependent protein kinase holoenzyme complex GO:0000307 8.62 CCND1 CDKN1A

Biological processes related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 23)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.76 BCL2 CCND1 IL2 IL6
2 negative regulation of apoptotic process GO:0043066 9.73 BCL2 CDKN1A IL2 IL6
3 immune response GO:0006955 9.71 B2M IGKC IL2 IL6
4 humoral immune response GO:0006959 9.61 BCL2 IL6
5 cell growth GO:0016049 9.61 BCL2 IL6
6 animal organ regeneration GO:0031100 9.6 CCND1 CDKN1A
7 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.59 BCL2 CDKN1A
8 retina homeostasis GO:0001895 9.58 B2M IGKC
9 response to organonitrogen compound GO:0010243 9.58 CCND1 CDKN1A
10 cellular response to organic substance GO:0071310 9.57 BCL2 CCND1
11 T cell differentiation GO:0030217 9.56 BCL2 IL2
12 response to steroid hormone GO:0048545 9.55 BCL2 CCND1
13 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.54 BCL2 IL2
14 response to organic cyclic compound GO:0014070 9.54 CCND1 CDKN1A IL6
15 T cell differentiation in thymus GO:0033077 9.52 B2M BCL2
16 response to X-ray GO:0010165 9.51 CCND1 CDKN1A
17 regulation of cell cycle GO:0051726 9.5 BCL2 CCND1 CDKN1A
18 response to iron ion GO:0010039 9.49 BCL2 CCND1
19 response to corticosterone GO:0051412 9.48 CCND1 CDKN1A
20 response to drug GO:0042493 9.35 B2M BCL2 CCND1 CDKN1A IL6
21 positive regulation of B cell proliferation GO:0030890 9.33 BCL2 CDKN1A IL2
22 positive regulation of immunoglobulin secretion GO:0051024 9.26 IL2 IL6
23 response to glucocorticoid GO:0051384 8.92 BCL2 CCND1 CDKN1A IL6

Molecular functions related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein serine/threonine kinase activity GO:0004693 8.62 CCND1 CDKN1A

Sources for Extramedullary Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....